Houry Leblebjian

Extramedullary Waldenström macroglobulinemia

Ranjit Banwait, Yosra Aljawai, Joseph M. Cappuccio et al. · American Journal of Hematology · 2014 · 67 citations · Full text

Immunology, Extramedullary Waldenström Macroglobulinemia, Pathology +16

Live Attenuated Varicella-Zoster Vaccine in Hematopoietic Stem Cell Transplantation Recipients

Nicolas C. Issa, Francisco M. Marty, Houry Leblebjian et al. · Biology of Blood and Marrow Transplantation · 2013 · 60 citations · Full text

Vaccination, Vaccine Safety, Transplantation +12

Phase I/II trial of the CXCR4 inhibitor plerixafor in combination with bortezomib as a chemosensitization strategy in relapsed/refractory multiple myeloma

Irene M. Ghobrial, Chia‐Jen Liu, Oksana Zavidij et al. · American Journal of Hematology · 2019 · 60 citations · Full text

Phase I/II trial of everolimus in combination with bortezomib and rituximab (RVR) in relapsed/refractory Waldenstrom macroglobulinemia

Irene M. Ghobrial, Robert Redd, Philippe Armand et al. · Leukemia · 2015 · 32 citations

Immunology, Phase I/ii Trial, Immunotherapy +2

Predictive factors for all-trans retinoic acid-related differentiation syndrome in patients with acute promyelocytic leukemia

Houry Leblebjian, Daniel J. DeAngelo, J. Andrew Skirvin et al. · Leukemia Research · 2013 · 22 citations

Hematological Malignancy, Predictive Factors, Mixed-phenotype Acute Leukemia +8